• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year

    Grifols Introduces its First Plasma Protein-Based Biosurgery Product

    RSNA News: MaxQ AI Expands Partnership with GE

    RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

    Levita Magnetics Reaches 1,000th Magnetic Surgery Milestone
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    S-Y-M Products Company

    Command Medical Products Inc.

    Marox Corporation

    Halkey-Roberts Corporation

    Zeus
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices

    Revenue-Based Financing: A New Form of Growth Capital

    Pre-Filled Safety Syringes and the Self-Administration Trend

    6 Ways Machine Learning-Enabled Virtual Assistants Can Serve Doctors and Patients
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Eurofins Medical Device Testing

    Cadence Inc.

    Aran Biomedical

    Lyons

    NN Life Sciences/Paragon Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Used Medical Equipment: A Source of Anxiety for the FDA

    Used Medical Equipment: A Source of Anxiety for the FDA
    Related CONTENT
    • Sterilization Innovations Lead to New Guidance Document
    • Stakeholders Anticipate FDA Action on Third-Party Repairs
    • Making the Case for an Integrated QMS-BMS
    • To Pursue or Not to Pursue? The Value of a CE Mark
    • Does Your Top Management Undervalue the Regulatory Function?
    James A. Dunning, CEO, QPC Services11.08.16
    An eBay search for medical devices (listed under the medical equipment category) is likely to yield various types of used medical equipment—magnetic resonance imaging machines, for example, negative pressure wound therapy systems, X-ray machines, infusion pumps, and heart-lung machines, among others.

    For many years, the U.S. Food and Drug Administration (FDA) has sought to clarify its regulatory requirements and expectations under 21 CFR Part 820 to entities servicing, refurbishing, rebuilding, reconditioning, remarketing, and remanufacturing medical devices. In addition, FDA medical device regulations mandate that device manufacturers establish and maintain instructions and procedures for servicing. However, in the Dec. 4, 1998 Federal Register (63 FR 67076), medical devices were excluded from compliance with the 1997 Quality System Regulation.

    Since then, the FDA has established some regulatory requirements for refurbished/serviced medical equipment. The Electronic Product Radiation Control requirements of the Food, Drug and Cosmetic Act (Pub. L. 90-602, amended by Pub. L. 103-80), include provisions specific to manufacturers and assemblers of certified X-ray components. Under 21 CFR Part 1020.30(c), manufacturers of diagnostic X-ray systems are responsible for providing assembly instructions adequate to ensure compliance of their components with the applicable performance standards when installed properly. Furthermore, under 21 CFR Part 1020.30(d), assemblers are required to assemble, install, adjust, and test the certified components according to the instructions of their respective manufacturers. The FDA has previously issued guidance on these topics, including an Assembler’s Guide to Diagnostic X-ray Equipment and Information Disclosure by Manufacturers to Assemblers for Diagnostic X-ray Systems. Under the EPRC provision in 21 CFR 1040.10(h)(1)(i), manufacturers of laser products must provide instructions for assembly, operation, and maintenance, including warnings and precautions on how to avoid exposure, and maintenance schedules to ensure the product complies with standard requirements.

    Yet the current regulations are unsatisfactory for many medtech executives and policymakers. The FDA, for example, is concerned that third-party entities who refurbish, recondition, rebuild, remarket, remanufacture, service, and repair medical devices could use unqualified personnel to perform service, maintenance, refurbishment, and device alterations on their equipment. The agency also worries about adequate documentation of the work and potential public health issues arising from these activities. Some specific concerns are:
    1. Improper device operation
    2. Faulty device safety systems
    3. Ineffective recalls 
    Earlier this year, the FDA issued a docket to request feedback from the industry, particularly those involved in the activities previously noted or who utilize refurbished, reconditioned, rebuilt, remarketed, remanufactured, or third-party serviced and repaired medical devices. The docket, FDA claims, was triggered by concerns about the quality, safety, and continued effectiveness of used medical devices handled by original equipment manufacturers (OEM) and third parties, including healthcare establishments. The docket asks for input on the following proposed definitions:
    1. Recondition: Restores and/or refurbishes a medical device to the OEM’s original specifications. Under limited circumstances, the medical device may be restored and/or refurbished to current specifications.
    2. Service: Maintenance or repair of a finished device after distribution for purposes of returning it to the safety and performance specifications established by the OEM and to meet its original intended use. Servicing cannot change the intended use(s) of the device from its original purpose(s).
    3. Repair: Return the device or component to original specifications, including replacing non-working components or parts outside of routine or periodic upkeep for the  current owner of the device.
    4. Refurbish: Restore device to a condition of safety and effectiveness that is comparable to when new. This includes reconditioning, repair, installation of certain software/hardware updates that do not change the intended use of the original device, and replacement of worn parts.
    5. Remanufacture: Process, condition, renovate, repackage, restore, or any other act done to a finished device that significantly changes the finished device’s performance, safety specifications, or intended use.
    6. Remarket: The act of facilitating the transfer of a previously owned device from one party to another by sale, donation, gift, or lease.
    Besides requesting comments on these definitions, the FDA wants feedback about their associated benefits and risks. Feedback is welcomed on the following questions: 
    1. Who are the different stakeholders involved with the medical device activities listed previously? What are their respective roles?
    2. What evidence exists regarding actual problems with the safety and/or performance of devices that result from these activities? Specific examples should be submitted.
    3. What are the potential risks (patients/users) and failure modes (devices) introduced as a result of performing the previously defined activities on medical devices? Please speak to issues common to all devices as well as specific risks with specific devices.
    4. These activities are performed by OEMs and various third-party entities, including hospitals and humanitarian organizations. Are the risks different depending on who performs the previously mentioned activities?
    5. We are interested in knowing if these activities are more difficult or riskier to perform on certain devices versus others. Please cite specific examples in your response, along with an explanation of the source of this particular complexity.
    6. What information do third-party entities need in order to perform these activities in a way that results in safe and effective operation of the medical device? Provide specific examples.
    7. What additional challenges do stakeholders encounter with devices that result from these activities?
    The following three excerpts were extracted from the more than 175 comments submitted thus far to the FDA. The full list of comments is available at bit.ly/mpo161250.

    Comment Excerpt (1) 
    In the industry of third-party ultrasound equipment repair, a wide range of interpretations and definitions exist about how to restore and/or refurbish ultrasound medical devices back to a quality healthcare facilities expect. Third parties attempt to remanufacture critical parts of the medical device, but to a specification they believe to be standard operational conditions. For example, a critical part may be remanufactured to a specification that they feel matches performance needs; however, the holistic characteristics such as ergonomics, temperature control, HIPOT, leakage, and form factor are often ignored. These issues are the same for third-party companies attempting to make any changes to medical devices to a newer specification.

    Using non-OEM measuring devices to analyze transducers is also a common practice with some repair facilities. These devices are ultrasound machine simulators that provide snapshots and do not properly capture intermittent issues that require more intensive testing. This method is fine when used in conjunction with the intended testing machines the devices are used on, but cannot be used solely as a substitute. There are certain features, such as thermal monitoring and electromechanical control mechanisms, that can only be properly tested for functionality or faults on a native ultrasound machine.

    The customer is often unaware of the low-quality remanufactured components inside ultrasound transducers because they are encased inside the outer body shell. This poses an ethical issue of disclosing what the customer is ordering relative to the OEM part number requested. If the transducer does not have OEM parts and materials, it should be disclosed at the time of sale to the hospital. This disclosure provides the opportunity to avoid unnecessary safety risks.

    Comment Excerpt (2)
    In over 25 years of laser service, we have not had any safety or performance issues reported as a result of our technicians servicing equipment. I do recall a recent occasion in which a customer called us to service a laser that was one year old, just out of warranty, in which they were having problems with. The OEM had serviced the unit and found no problem. Our technician found a factory defect in which metal shavings were left in the articulated arm, causing focusing issues for the customer. The OEM technician was not able to find the problem, but our technician did.

    We require our technicians have formal electronic or biomedical training. There are multiple OEMs that subcontract us to perform service on their behalf.

    Comment Excerpt (3)
    If there is a lack of uniform performance, its genesis may be the failure of some original equipment manufacturers to readily supply AIAT [Assemble-Install-Adjust-Test] information. IAMERS [International Association of Medical Equipment Remarketers and Servicers] has continually expressed concerns that some original equipment manufacturers have consistently failed to fulfill disclosure requirements. Under the relevant regulations, including those in Title 21 of the Code of Federal Regulation, Parts 820.170 and 1020.30, OEMS are required to provide certain information to third-party servicers and installers. As the FDA has noted, “...it is the FDA’s responsibility to hold OEMs accountable for providing required information to third parties where appropriate for ensuring the safe and effective operation of medical devices.”

    Conclusion
    In researching this column and reading many of the comments submitted to the FDA, several key issues became obvious:
    • OEMs and third-party service organizations have a clear point of view about servicing and repairing refurbished or reprocessed devices.
    • The FDA‘s concerns about device service and repair by OEMs and third-party service organizations have not changed in 20 years.
    • The patient must be the main concern of any organization involved in servicing medical equipment.
    Third-party service organizations provide a critical service, particularly in cases when OEMs announce the end of life for their medical equipment. Although many users will upgrade—which is almost always an option—many may not, especially users who cannot afford to update to the most current technology. Thus, the current level of regulatory oversight is concerning to many organizations.

    I sincerely hope the FDA issues additional regulatory requirements for third-party service organizations and OEMs that service their own equipment. An update is long overdue. 


    James A. “Jim” Dunning’s consulting career began in 2001. He has provided quality and regulatory consulting services for various companies ranging from Fortune 500 medical device firms to startups. Dunning’s passion, however, lies with startups and small companies, especially those in regulatory distress. He has amassed significant experience in preparing 510(k) applications, developing complete Quality Management Systems, providing Quality System Training, and advising on quality, business, and leadership issues. Dunning is a senior member of the American Society for Quality (ASQ) and a member of the Regulatory Affairs Professional Society (RAPS). He can be reached at jdunning@qpcservices.com 
    Related Searches
    • lifepak 1000 defibrillator
    Suggested For You
    Mercury Biomed Awarded NIH Grant Mercury Biomed Awarded NIH Grant
    Positive Results from Boston Scientific Positive Results from Boston Scientific's Bronchial Thermoplasty Study
    NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology
    Samsung Launches Versatile Ultrasound Systems Designed to Enhance the User Experience Samsung Launches Versatile Ultrasound Systems Designed to Enhance the User Experience
     Crospon Receives 510(k) FDA Clearance for Endoflip with Flip Topography Module Crospon Receives 510(k) FDA Clearance for Endoflip with Flip Topography Module
    Current Good Manufacturing Practices: Pharma vs. Device Current Good Manufacturing Practices: Pharma vs. Device
    Integrating Training and Document Control with Automated Solutions Integrating Training and Document Control with Automated Solutions
    Verification Matters Verification Matters
    Don’t Blame ISO for Inefficient Operations Don’t Blame ISO for Inefficient Operations
    FDA Updating Guidance on 510(k) Submissions for Product Software Changes FDA Updating Guidance on 510(k) Submissions for Product Software Changes
    Does Your Top Management Undervalue the Regulatory Function? Does Your Top Management Undervalue the Regulatory Function?
    To Pursue or Not to Pursue? The Value of a CE Mark To Pursue or Not to Pursue? The Value of a CE Mark
    Making the Case for an Integrated QMS-BMS Making the Case for an Integrated QMS-BMS
    Stakeholders Anticipate FDA Action on Third-Party Repairs Stakeholders Anticipate FDA Action on Third-Party Repairs
    Sterilization Innovations Lead to New Guidance Document Sterilization Innovations Lead to New Guidance Document

    Related Columns

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Digital Health
      An Update on Digital Health

      An Update on Digital Health

      Sure, most are startups—but not all. There were some brilliant ideas presented at The MedTech Conference (AdvaMed’s annual meeting) on Sept. 23-25 in Boston and the Connected Health Conference, also in Boston, put on by Partners Health…
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 11.04.19


    • Five Steps for Succeeding Globally in Medtech

      Five Steps for Succeeding Globally in Medtech

      World views can differ considerably, so it is important to understand, appreciate, and respect cultural realities and differences.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.19

    • Software & IT
      Unlocking Market Doors with Real-World Evidence

      Unlocking Market Doors with Real-World Evidence

      Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.
      Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 11.04.19

    • Contract Manufacturing
      Sales Tips for Contract Manufacturers of Finished Devices

      Sales Tips for Contract Manufacturers of Finished Devices

      Evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.04.19


    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 11.04.19

    • R&D & Design
      Perfecting Drug Delivery Device Design

      Perfecting Drug Delivery Device Design

      Unlike medical products that just need to work, drug delivery devices must also consider intuitiveness, usability, and how it makes the user feel when operated.
      Bryce G. Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • A Look at Physician/Surgeon Salary and Employment Statistics

      A Look at Physician/Surgeon Salary and Employment Statistics

      No more call for physicians? Not really, but schedule predictability is in for physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 10.08.19

    • Bridging Generation Gaps to Build Better Teams and Business

      Bridging Generation Gaps to Build Better Teams and Business

      I’ve learned the hard way that building teams of motivated, productive employees is equal parts science and art.
      Dawn A. Lissy, President & Founder, Empirical 10.08.19

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      One of the latest concerns—arising from an old issue—is the medical device tax, which could return next year without legislative intervention before then.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 10.08.19

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19


    Breaking News
    • Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    • Grifols Introduces its First Plasma Protein-Based Biosurgery Product
    • RSNA News: MaxQ AI Expands Partnership with GE
    • RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform
    • Levita Magnetics Reaches 1,000th Magnetic Surgery Milestone
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Sabinsa Gains Patent for LactoSpore Probiotic
    DuPont Launches Ingredient Solutions for Plant-Based Innovation
    Coatings World

    Latest Breaking News From Coatings World

    BASF Doubling Automotive Refinish Coatings Production Capacity at Jiangmen, China Site
    AkzoNobel’s Wanda Vehicle Refinishes Brand Celebrates 85th Anniversary
    Pursuit of Balance Inspires Pratt & Lambert’s 2020 Color of the Year
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Grifols Introduces its First Plasma Protein-Based Biosurgery Product
    RSNA News: MaxQ AI Expands Partnership with GE
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Recipharm, RedHill Biopharma Ink Commercial Mfg. Pact
    PCI Completes Expansion of Specialty Drug Product Capabilities
    IONTAS, Adaptate Enter Antibodies Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Lancôme Inaugurates First Flagship in Paris
    Beautycounter Founder & CEO Testifies in House Cosmetic Reform Hearing
    Gina Boswell Joins Geltor’s Board of Directors
    Happi

    Latest Breaking News From Happi

    Classic Blue is Pantone Color of the Year 2020
    ChapStick Offers Holiday Surprises
    Rethink a Link Between Hair Color and Cancer
    Ink World

    Latest Breaking News From Ink World

    Graphic Village Expands Offerings with Canon Solutions America
    Anvy Digital Reports Increased Revenue with SpyderX
    BASF Doubling Automotive Refinish Coatings Production Capacity at Jiangmen, China Site
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Schreiner MediPharm and PragmatIC form strategic partnership
    Herma's labelstocks receive new certification
    MPS Systems North America relocating to Philadelphia
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Optima Packaging Honored at Regional Competition
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    3D-Printed Graftless Bone Transplants Go to Clinical Trials
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    CES 2020: 'Where Tech Changes Business'
    Global Flexible Display Market Size to Increase at a CAGR of 28.1% Through 2025: GVR
    CPI Printed Sensors Project Aims to Reduce Cost, Increase Efficiency of EV Batteries

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.